Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 25, 2023
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
Corinne Jenkins Maintained (TGTX) at Strong Sell with Increased Target to $16 on, Jul 25th, 2023
Corinne Jenkins of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Sell with Increased Target from $10 to $16 on, Jul 25th, 2023.
Corinne has made no other calls on TGTX in the last 4 months.
There are 4 other peers that have a rating on TGTX. Out of the 4 peers that are also analyzing TGTX, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Corinne
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $42 on, Thursday, July 13th, 2023
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $34 on, Thursday, June 1st, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, May 2nd, 2023
- Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
